Search Results
Test Catalog
GLSF - Overview: Glucose, Spinal Fluid
Investigating possible central nervous system infection
HGHAR - Overview: Mercury, Hair
Detecting mercury exposure in hair specimens
APRI - Overview: Prolonged Clot Time Profile Interpretation
Interpretation of testing performed as part of a profile to determine the cause of prolongation of prothrombin time or activated partial thromboplastin time Interpretation of testing performed as part of a profile for screening for...
FIBDD - Overview: PROMETHEUS IBD sgi Diagnostic
PROMETHEUS IBD sgi Diagnostic
ASHA - Overview: Arsenic, Hair
Detection of nonacute arsenic exposure in hair specimens
NH3V - Overview: Ammonia, Plasma
Assisting in the diagnosis of hepatic coma Investigating and monitoring treatment for inborn errors of metabolism Evaluating patients with advanced liver disease
ALBSF - Overview: Albumin, Spinal Fluid
Assessment of blood-brain barrier permeability
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
FLEC - Overview: Flecainide, Serum
Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance
CATTR - Overview: Cold Agglutinin Titer, Serum
Detection of cold agglutinins in patients with suspected cold agglutinin disease This test is not recommended to diagnose Mycoplasma pneumoniae infections.
CDP - Overview: Chlordiazepoxide and Metabolite, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
CAFF - Overview: Caffeine, Serum
Monitoring caffeine therapy in neonates Assessing caffeine toxicity in neonates
CZPS - Overview: Clonazepam and 7-Aminoclonazepam, Serum
Assessing patient compliance Monitoring for appropriate therapeutic level Assessing clonazepam toxicity
CDB - Overview: Cadmium, Blood
Detecting exposure to cadmium, a toxic heavy metal
ETGL - Overview: Ethylene Glycol, Serum
Confirming and monitoring ethylene glycol toxicity
CDOMB - Overview: Cadmium for Occupational Monitoring, Blood
Detecting exposure to cadmium, a toxic heavy metal, as a part of occupational monitoring
HKC - Overview: Hexokinase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
HK1 - Overview: Hexokinase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
LITH - Overview: Lithium, Serum
Monitoring therapy of patients with bipolar disorders, including recurrent episodes of mania and depression Evaluating lithium toxicity
MEX - Overview: Mexiletine, Serum
Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity
UNHB - Overview: Hemoglobin Stability, Blood
Work-up of congenital hemolytic anemias
QUIN - Overview: Quinidine, Serum
Assessing and adjusting quinidine dosage for optimal therapeutic level Assessing quinidine toxicity
OXYMU - Overview: Oxymorphone Confirmation, Random, Urine
Detection and quantification of oxymorphone and noroxymorphone in urine
TPSF - Overview: Protein, Total, Spinal Fluid
Detecting disruptions of the blood-brain barrier or intrathecal synthesis of immunoglobulins
UOSMS - Overview: Osmolality, Serum
Evaluating acutely ill or comatose patients
RPHOC - Overview: Phosphorus, Random, Urine
Evaluation of hypo- or hyperphosphatemic states Evaluation of patients with nephrolithiasis
TAPEN - Overview: Tapentadol and Metabolite, Random, Urine
Monitoring of compliance utilizing tapentadol Detection and confirmation of the illicit use of tapentadol This test is not intended for use in employment-related testing.
TPI1 - Overview: Triosephosphate Isomerase Enzyme Activity, Blood
Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency
SEWB - Overview: Selenium, Blood
Assessment of tissue stores of selenium
TOBTA - Overview: Tobramycin, Trough, Serum
Monitoring adequate clearance of tobramycin near the end of a dosing cycle
TOBPA - Overview: Tobramycin, Peak, Serum
Monitoring adequacy of serum concentration during tobramycin therapy
SOLFM - Overview: Soluble Fibrin Monomer, Plasma
Assisting in the diagnosis of arterial or venous prethrombotic states in various pathological and clinical situations including disseminated intravascular coagulation/intravascular coagulation and fibrinolysis and postoperative monitoring...
SECOS - Overview: Secobarbital, Serum
Monitoring secobarbital therapy
URCON - Overview: Urea, Random, Urine
Assessment of kidney failure (prerenal vs acute kidney injury)
HEXAZ - Overview: Tay-Sachs Disease, HEXA Gene, Full Gene Analysis, Varies
Second-tier test for confirming a biochemical diagnosis of Tay-Sachs disease (TSD) Carrier testing of individuals with a family history of TSD but an affected individual is not available for testing or disease-causing mutations have not...
ACE - Overview: Angiotensin Converting Enzyme, Serum
Evaluation of patients with suspected sarcoidosis
COL7 - Overview: Anti-Collagen type VII, IgG Antibodies, Serum
Initial screening test in the diagnosis of epidermolysis bullosa acquisita and other immunobullous diseases mediated by collagen VII
AMS - Overview: Amylase, Total, Serum
Diagnosis and management of pancreatitis Evaluation of pancreatic function
PAMIK - Overview: Amikacin, Peak, Serum
Monitoring adequacy of serum concentration during amikacin therapy
RAMBO - Overview: Ammonium, Random, Urine
Diagnosis of the cause of acidosis using random urine specimens Diagnosis and treatment of kidney stones
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
BHYD - Overview: Beta-Hydroxybutyrate, Serum
Monitoring therapy for diabetic ketoacidosis Investigating the differential diagnosis of any patient presenting to the emergency room with hypoglycemia, acidosis, suspected alcohol ingestion, or an unexplained increase in the anion gap...
AMIO - Overview: Amiodarone, Serum
Monitoring amiodarone therapy, especially when amiodarone is coadministered with other drugs that may interact Evaluating possible amiodarone toxicity Assessing patient compliance
F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
F5_IS - Overview: Factor V Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor V
F2_IS - Overview: Factor II Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor II
CK - Overview: Creatine Kinase (CK), Serum
Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury
CEASF - Overview: Carcinoembryonic Antigen (CEA), Spinal Fluid
Detecting meningeal carcinomatosis and intradural or extradural infiltration Differentiating brain parenchymal metastasis from adenocarcinoma or squamous-cell carcinoma
Site Search
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men....
https://www.mayocliniclabs.com/it-mmfiles/cpt-code-changes.xlsx
note, CPT Code changes listed on this document are effective January 1st, 2025.*** ***Updates and other changes may occur, and be reflected on this document, leading up to 2025*** ***CPT Code Updates...
CPT Codes and LOINC Update: September 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of September 2019....
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information MC1235297
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information Complete print Reset Form Primary Ciliary Dyskinesia Genetic Testing Patient Information Instructions Accurate interpretation reporting...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing...